Bliss GVS Pharma Limited will hold a board meeting on Wednesday, August 12, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, according to a regulatory filing. The trading window for designated persons and their immediate relatives was closed from July 1, 2026, and will remain closed until 48 hours after the announcement of the financial results.